The WHO’s Department of Vaccines and Biologicals will be providing seed-funding for research projects on vaccine delivery and stabilisation technologies. These studies should be targeted towards developing country populations (including infants and young children) and formulations/antigens should target at least one of a few selected priority diseases/disease agents in our program: human papilloma virus, tuberculosis, shigella, enterotoxicogenic Escherichia coli and malaria.
Details here
Address: IVR/BAC
WHO
20 Avenue Appia
1211 Geneva
Switzerland
Email: deanm@who.int
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber?
Please or to read this article.
